Pages that link to "Q73221180"
Jump to navigation
Jump to search
The following pages link to Expression of cyclooxygenase-2 in human gastric carcinoma (Q73221180):
Displaying 50 items.
- Natural selection of tumor variants in the generation of "tumor escape" phenotypes (Q24551158) (← links)
- Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation (Q24645394) (← links)
- Pharmacological basis for the therapy of pain and inflammation with nonsteroidal anti-inflammatory drugs (Q24792554) (← links)
- Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway (Q24806402) (← links)
- Molecular alterations in gastric cancer with special reference to the early-onset subtype (Q26764919) (← links)
- COX-2 Inhibitors and Gastric Cancer (Q27692701) (← links)
- The Anticancer Properties of Herba Epimedii and Its Main Bioactive Componentsicariin and Icariside II (Q28070895) (← links)
- Clinical pharmacology of the selective COX-2 inhibitors (Q28166337) (← links)
- Do nonsteroidal anti-inflammatory drugs affect the risk of developing ovarian cancer? A meta-analysis (Q28185207) (← links)
- Oesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesis (Q28195678) (← links)
- Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience (Q28303196) (← links)
- Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma (Q28360358) (← links)
- α-Mangostin extracted from the pericarp of the mangosteen (Garcinia mangostana Linn) reduces tumor growth and lymph node metastasis in an immunocompetent xenograft model of metastatic mammary cancer carrying a p53 mutation (Q28389681) (← links)
- Inhibition mechanism of the intracellular transporter Ca2+-pump from sarco-endoplasmic reticulum by the antitumor agent dimethyl-celecoxib (Q28540515) (← links)
- Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial (Q28551492) (← links)
- Apoptosis of human gastric cancer SGC-7901 cells induced by mitomycin combined with sulindac (Q31156666) (← links)
- Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus (Q33244119) (← links)
- Nature meets nurture: molecular genetics of gastric cancer. (Q33347546) (← links)
- Polymorphism in COX-2 modifies the inverse association between Helicobacter pylori seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study (Q33451033) (← links)
- Cytotoxic necrotizing factor from Escherichia coli induces RhoA-dependent expression of the cyclooxygenase-2 Gene (Q33552763) (← links)
- Dose-dependent reduction of 3,2'-dimethyl-4-aminobiphenyl-derived DNA adducts in colon and liver of rats administered celecoxib (Q33613090) (← links)
- Biological activity of celecoxib in the bronchial epithelium of current and former smokers (Q33640402) (← links)
- Non-Steroidal Anti-Inflammatory Drugs in the Carcinogenesis of the Gastrointestinal Tract (Q33664095) (← links)
- Repression of caspase-3 and RNA-binding protein HuR cleavage by cyclooxygenase-2 promotes drug resistance in oral squamous cell carcinoma (Q33752554) (← links)
- Relationship between 15-hydroxyprostaglandin dehydrogenase and gastric adenocarcinoma (Q33773701) (← links)
- Epidemiology of gastric cancer (Q33788193) (← links)
- Wnt/β-catenin signaling enhances cyclooxygenase-2 (COX2) transcriptional activity in gastric cancer cells (Q33873644) (← links)
- At the bedside: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer. (Q33911623) (← links)
- Cellular and molecular aspects of gastric cancer. (Q34012910) (← links)
- Expression of HuR and Cyclooxygenase-2 in Nodular Fasciitis and Low-Grade Sarcoma: An Immunohistochemical Study (Q34161932) (← links)
- Helicobacter pylori and gastric cancer: factors that modulate disease risk (Q34189885) (← links)
- Helicobacter pylori infection, gastrin and cyclooxygenase-2 in gastric carcinogenesis (Q34255451) (← links)
- Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1 (Q34302223) (← links)
- Cyclooxygenase-2 polymorphisms and susceptibility to gastric carcinoma: A meta-analysis (Q34333203) (← links)
- Prognostic role of host cyclooxygenase and cytokine genotypes in a Caucasian cohort of patients with gastric adenocarcinoma (Q34430932) (← links)
- Chemopreventive properties of black raspberries in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis: down-regulation of cyclooxygenase-2, inducible nitric oxide synthase, and c-Jun (Q34462544) (← links)
- Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model (Q34536921) (← links)
- Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications (Q34567287) (← links)
- Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma (Q34786102) (← links)
- Induction of cyclooxygenase-2 in monocyte/macrophage by mucins secreted from colon cancer cells. (Q34808316) (← links)
- Functional modulation of the metastatic suppressor Nm23-H1 by oncogenic viruses (Q34901718) (← links)
- Inhibition of the JAK2/STAT3 pathway reduces gastric cancer growth in vitro and in vivo (Q35164307) (← links)
- Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2. (Q35289963) (← links)
- Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma (Q35362299) (← links)
- Expression of cyclooxygenase-2 in gastric cancer and its relation to liver metastasis and long-term prognosis (Q35435907) (← links)
- The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy (Q35547038) (← links)
- Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells (Q35556908) (← links)
- Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. (Q35574131) (← links)
- Blisters in the small intestinal mucosa of coeliac patients contain T cells positive for cyclooxygenase 2. (Q35594245) (← links)
- A multiscale systems perspective on cancer, immunotherapy, and Interleukin-12 (Q35624686) (← links)